PT Soho Global Health Tbk (the Company), was established in Jakarta based on Notarial Deed No. 116 of Elisa Pondaag, S.H., dated August 27, 1956 under the name of PT Parit Padang. The Company started its commercial activitiesin 1956.
| Nama | Domisili | % |
|---|---|---|
|
PT Soho Industri Pharmasi
Pharmaceutical industry
|
Jakarta | 99,64% |
|
PT Parit Padang Global
Pharmaceutical distributor
|
Jakarta | 99,99% |
|
PT Universal Health Network
Pharmaceutical multi-level marketing
|
Jakarta | 99,98% |
|
PT Soho Global Medika
Medical devices distributor
|
Jakarta | 99,80% |
| Periode | Sales | Net Income | EPS | ROE | ROA | DER | Total Assets | Book Value |
|---|---|---|---|---|---|---|---|---|
| 2026 Q2 | 5,36 T | 372,92 M | 58,77 | 30,39% | 13,33% | 1,28x | 5,59 T | 193,40 |
| 2026 Q1 | 2,64 T | 189,86 M | 59,84 | 27,39% | 13,10% | 1,09x | 5,80 T | 218,48 |
| 2025 Q4 | 10,78 T | 600,32 M | 47,30 | 23,24% | 9,75% | 1,38x | 6,16 T | 203,52 |
| 2025 Q3 | 7,92 T | 440,09 M | 46,23 | 20,61% | 9,77% | 1,11x | 6,01 T | 224,32 |
| 2025 Q2 | 5,17 T | 290,36 M | 45,76 | 21,47% | 10,60% | 1,03x | 5,48 T | 213,11 |
| 2025 Q1 | 2,67 T | 133,25 M | 41,99 | 18,71% | 9,69% | 0,93x | 5,50 T | 224,44 |
| Kategori | Domestik | Asing |
|---|---|---|
| Korporasi | 900 0,00% | 5.322.723.450 41,94% |
| Individu | 1.154.154.770 9,09% | 1.283.000 0,01% |
| Reksa Dana | 0 | 1.131.874.000 8,92% |
| Perusahaan Efek | 100 0,00% | 5.080.611.670 40,03% |
| Institusi Keuangan / Bank | 0 | 1.034.500 0,01% |
| Total | 1.154.155.770 9,09% | 11.537.526.620 90,91% |
| Tanggal | Jenis | Harga |
|---|---|---|
| 8 Sep 2020 | Result Execution of Convertible Notes | 500 |
| 8 Sep 2020 | Result Execution of Warrant | 500 |
| 8 Sep 2020 | Result Program Management Incentive Plan Tahap I and II | 500 |
| 8 Sep 2020 | IPO @ Rp 1,820 | 500 |
| 8 Sep 2020 | Founder Shares | 500 |
| 13 Nov 2023 | Stock Split 500 : 50 | 50 |
All market data is a real-time snapshot, delayed at least 10 minute, except where indicated otherwise. All market data presented in this website have been permitted by the Indonesian Stock Exchange. All market data and analysis information provided "as is" for informational purposes only, not intended for trading purposes or advice. IQ Plus is not liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the IQPLUS.info site, you agree not to redistribute the information found therein. All quotes are in West Indonesia Standard Time (WIB).
Komplek Gading Bukit Indah, Blok H24,
Kelapa Gading, Jakarta Utara 14240
Phone : 021-4513821
Email : marketing@iqplus.info
